Difficulty: Intermediate | Prerequisites: Part 1 of these notes (DNA analysis techniques, gene cloning, and DNA libraries). Familiarity with DNA replication and nucleotide structure.
Once scientists had the tools to cut, clone, and screen DNA (covered in Part 1), the next challenge was reading entire genomes. This section covers the sequencing methods that made the Human Genome Project possible, the project itself, and some of the medical and diagnostic applications that followed. If Part 1 was about building the workshop, Part 2 is about using it to read the whole instruction manual and then applying what it says.
Sanger sequencing uses ddNTPs to terminate DNA replication at every possible position, producing fragments that reveal the sequence. Chromosome walking and shotgun sequencing were competing strategies for tackling whole genomes. The Human Genome Project aimed to sequence all 3 billion base pairs and catalogue human genes. Downstream applications include identifying disease-associated genes (e.g. APOE4 for Alzheimer's) and preimplantation genetic diagnosis.
dNTP (deoxyribonucleoside triphosphate)
The standard building block for DNA replication. Each dNTP has a 3'-OH group on its sugar, which is essential for forming the next phosphodiester bond in the growing chain.
ddNTP (dideoxyribonucleoside triphosphate)
A modified nucleotide that lacks the 3'-OH group. When a ddNTP is incorporated during replication, no further nucleotides can be added, so the chain terminates at that position. Think of it as a brick with no socket on one end: you can snap it in, but nothing can attach after it.
Sanger sequencing (chain-termination sequencing, dideoxy sequencing)
A method for determining the nucleotide sequence of DNA. A mixture of dNTPs and a small proportion of fluorescently labelled ddNTPs is used in a replication reaction. The ddNTPs randomly terminate chains at every possible position, producing fragments of every length. These fragments are separated by size (capillary electrophoresis), and the terminal fluorescent label on each fragment reveals the identity of that position in the sequence.
Chromosome walking
A sequential strategy for mapping and sequencing a genome. You sequence one cloned fragment, use its end sequence to design a probe, screen the library for an overlapping clone, sequence that, and repeat. In simple terms, you inch along the chromosome one clone at a time.
Shotgun sequencing
A strategy that skips the orderly clone-by-clone approach. The entire genome is sheared into many small, random, overlapping fragments, all of which are sequenced simultaneously. A computer then assembles the fragments into a continuous sequence by matching overlaps. This required supercomputers and was the revolutionary technique that made whole-genome sequencing practical.
Human Genome Project (HGP)
An international research effort (1990–2003) whose goals included sequencing the entire 3 billion base pairs of human DNA, identifying all estimated 20,000–25,000 human genes, sequencing the genomes of model organisms important to medical research, and identifying genetic disorders. All of these were stated goals.
HapMap
A catalogue of common genetic variants (haplotypes) in the human genome. It maps patterns of SNPs across different populations and is used in genome-wide association studies to link variants to diseases. It is distinct from the sequencing techniques themselves.
Systems biology
An approach that studies biological systems as integrated wholes rather than focusing on individual pathways or genes. It draws on genomic, proteomic, and metabolomic data together. Not a sequencing technique per se, but a conceptual framework that became possible after large-scale sequencing.
Preimplantation genetic diagnosis (PGD)
The genetic profiling of embryos (created via IVF) before they are implanted in the uterus. A small number of cells are removed and tested for specific genetic conditions. In simple terms, it lets prospective parents screen embryos for known genetic disorders before pregnancy begins.
APOE4
An allele of the apolipoprotein E gene that is the strongest known genetic risk factor for late-onset Alzheimer's disease. It is not deterministic (carrying it does not guarantee the disease), but it significantly increases risk.
A normal dNTP has both a 2'-H (it is deoxy) and a 3'-OH on its sugar ring. The 3'-OH is where the next nucleotide attaches during chain elongation.
A ddNTP lacks the 3'-OH (it has a 3'-H instead). When DNA polymerase incorporates a ddNTP, there is no 3'-OH available to form the next phosphodiester bond, so replication halts immediately.
In a Sanger reaction, the ratio of dNTPs to ddNTPs is high, so termination events are random and rare at any given position. Over millions of molecules, every possible termination point is represented.
The result is a ladder of fragments differing by one nucleotide, which can be read as the sequence.
Chromosome walking proceeds one clone at a time in a linear, ordered fashion. It is thorough but slow, and it generates "dead ends" when repetitive sequences or unclonable regions are encountered.
Shotgun sequencing fragments the genome randomly and sequences everything in parallel. Assembly relies on computational overlap detection. It was the revolutionary method that required supercomputers and ultimately enabled the Human Genome Project to finish.
The original sequencing approaches (chromosome walking, forward genetics) failed to scale because:
Humans do not produce enough offspring for traditional recombination-based mapping.
Chromosome walking hits dead ends in repetitive regions.
Forward genetics identified only about 5% of protein-coding genes.
All three limitations contributed, making "all of the above" the correct exam answer.
Genome size: The human genome is approximately 3 billion (3 × 10^9) base pairs. This is the haploid number; a diploid cell contains roughly 6 billion base pairs across both sets of chromosomes. Exam questions typically ask for the haploid figure: 3 billion.
Goals of the HGP:
Sequence all 3 billion base pairs.
Identify the estimated 20,000–25,000 human genes.
Sequence the genomes of several model organisms (mouse, fruit fly, E. coli, yeast, C. elegans).
Identify genetic disorders.
All of the above were official goals.
The project was declared essentially complete in April 2003, with the truly gap-free "telomere-to-telomere" sequence of every chromosome finished later (T2T Consortium, 2022).
APOE4 is associated with Alzheimer's disease.
BRCA1 is associated with hereditary breast and ovarian cancer.
BRAF is associated with certain cancers (notably melanoma).
Myc is a well-known oncogene involved in many cancers.
XIAP is involved in apoptosis regulation.
For exam purposes, the pairing to know from this chapter is APOE4 and Alzheimer's.
PGD refers specifically to the genetic profiling of embryos prior to implantation.
It is not the same as RFLP, chromosome walking, or any sequencing technique. It is a clinical application that uses those techniques.
Common exam distractor: do not confuse PGD with prenatal genetic testing (amniocentesis, chorionic villus sampling), which occurs after implantation and during pregnancy.
Siddhartha Mukherjee is the author of The Gene: An Intimate History.
This is a course-specific factual point. Other books in the answer choices: The Selfish Gene (Richard Dawkins), A Short History of Nearly Everything (Bill Bryson), On the Origin of Species (Charles Darwin), The Double Helix (James Watson).
Expected number of restriction-enzyme cuts
Number of cuts = G / 4^n
Where G = genome size in base pairs and n = length of the recognition sequence.
4-cutter (n = 4): cuts every 256 bp on average.
6-cutter (n = 6): cuts every 4,096 bp on average.
8-cutter (n = 8): cuts every 65,536 bp on average.
Human genome size (haploid): 3 × 10^9 bp.
Shotgun sequencing (and its modern descendant, next-generation sequencing) is how clinical labs sequence patient genomes today for diagnostic purposes. The same computational assembly logic still applies.
PGD is routinely offered during IVF cycles to screen for conditions such as cystic fibrosis, sickle cell disease, and chromosomal aneuploidies.
APOE4 testing is available as a consumer genetic test (e.g. through direct-to-consumer services), though clinical guidelines vary on whether asymptomatic individuals should be tested.
Students often confuse the haploid genome size (3 billion bp) with the diploid total (6 billion bp). Exam questions almost always mean the haploid number unless they specify otherwise.
Shotgun sequencing and chromosome walking are sometimes mixed up. The distinguishing feature: shotgun is random and parallel; chromosome walking is ordered and sequential.
Students sometimes think ddNTPs lack the 2'-OH. That describes the difference between ribonucleotides and deoxyribonucleotides. The key feature of a ddNTP is the missing 3'-OH, which prevents chain elongation.
PGD is sometimes confused with prenatal testing. PGD happens before implantation (during IVF); prenatal testing happens during pregnancy.
⚠️ Know exactly what makes a ddNTP different from a dNTP (missing 3'-OH) and what consequence that has (chain termination). This is tested nearly every time.
⚠️ Be ready to distinguish chromosome walking (sequential, slow, dead ends) from shotgun sequencing (random, parallel, computer-assembled, required supercomputers).
⚠️ The Human Genome Project goals question often appears as "all of the above." Know all four stated goals.
⚠️ APOE4 = Alzheimer's. This is a straightforward recall question.
⚠️ PGD = genetic profiling of embryos before implantation. Do not confuse with any sequencing or mapping technique.
True or False: A ddNTP lacks a 2'-OH, which halts replication.
False. A ddNTP lacks the 3'-OH. (The 2'-OH distinction is between rNTPs and dNTPs.)
Fill in the blank: The technique that fragments the entire genome randomly and uses computers to reassemble overlapping reads is called ______ sequencing.
Shotgun.
True or False: The haploid human genome is approximately 6 billion base pairs.
False. The haploid genome is approximately 3 billion base pairs. The diploid total is 6 billion.
Fill in the blank: The gene most strongly associated with Alzheimer's disease risk in this chapter is ______.
APOE4.
True or False: Chromosome walking was the revolutionary technique that required supercomputers.
False. That was shotgun sequencing.
Q: How does a ddNTP differ from a dNTP, and what happens when a ddNTP is incorporated during replication?
A: A ddNTP lacks the 3'-OH group on its sugar. Without a 3'-OH, DNA polymerase cannot form the next phosphodiester bond, so chain elongation is terminated at that position.
Q: Why did the original approaches to sequencing the human genome fail?
A: Three converging problems: humans do not have enough offspring for classical recombination mapping, chromosome walking produces dead ends in repetitive regions, and forward genetics only identified roughly 5% of protein-coding genes.
Q: What were the goals of the Human Genome Project?
A: To sequence all 3 billion base pairs of the human genome, identify the estimated 20,000–25,000 human genes, sequence the genomes of key model organisms, and identify genetic disorders.
Q: What is preimplantation genetic diagnosis?
A: The genetic profiling of IVF embryos before they are transferred to the uterus, allowing screening for specific genetic conditions prior to pregnancy.
Q: Which sequencing method required supercomputers and was essential to completing the Human Genome Project?
A: The shotgun method.
Q: Chromosome walking involves sequencing one fragment at a time and using the end of that fragment to find the next overlapping clone. What is the main limitation of this approach?
A: It generates dead ends, particularly in repetitive regions of the genome where overlapping clones cannot be unambiguously identified.
Sanger sequencing connects to later chapters on next-generation sequencing (NGS), which replaced Sanger for high-throughput applications but still uses the same chain-termination logic conceptually.
The Human Genome Project is the foundation for everything in genomics, pharmacogenomics, and personalised medicine discussed later in most molecular biology courses.
PGD connects to bioethics discussions about genetic selection, designer babies, and the limits of reproductive technology, topics often revisited in upper-level genetics or bioethics modules.
ddNTP, dNTP, dideoxyribonucleoside triphosphate, deoxyribonucleoside triphosphate, Sanger sequencing, chain termination sequencing, dideoxy sequencing, 3'-OH, chain elongation, chromosome walking, shotgun sequencing, whole-genome sequencing, genome assembly, supercomputer, Human Genome Project, HGP, 3 billion base pairs, haploid genome, model organisms, HapMap, haplotype, systems biology, APOE4, Alzheimer's disease, BRCA1, BRAF, Myc, XIAP, preimplantation genetic diagnosis, PGD, IVF genetic screening, Siddhartha Mukherjee, The Gene An Intimate History, molecular biology chapter 7, UCF molecular biology